Annual EBITDA
-$87.60 M
-$860.00 K-0.99%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual EBITDA is -$87.60 million, with the most recent change of -$860.00 thousand (-0.99%) on December 31, 2023.
- During the last 3 years, FUSN annual EBITDA has fallen by -$50.15 million (-133.89%).
Performance
FUSN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$31.69 M
-$6.51 M-25.84%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly EBITDA is -$31.69 million, with the most recent change of -$6.51 million (-25.84%) on March 31, 2024.
- Over the past year, FUSN quarterly EBITDA has dropped by -$15.89 million (-100.52%).
Performance
FUSN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$96.49 M
-$8.89 M-10.15%
March 31, 2024
Summary
- As of February 10, 2025, FUSN TTM EBITDA is -$96.49 million, with the most recent change of -$8.89 million (-10.15%) on March 31, 2024.
- Over the past year, FUSN TTM EBITDA has dropped by -$10.53 million (-12.25%).
Performance
FUSN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
FUSN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.0% | -100.5% | -12.3% |
| 3 y3 years | -133.9% | -100.5% | -12.3% |
| 5 y5 years | -807.8% | -100.5% | -12.3% |
FUSN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +8.8% | at low | +100.5% | at low | +28.8% | at low |
| 5 y | 5-year | +393.4% | at low | +426.6% | at low | +443.5% | at low |
| alltime | all time | +1158.1% | at low | +735.6% | +117.8% | +443.5% | +44.7% |
Fusion Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$31.69 M(+25.8%) | -$96.49 M(+10.1%) |
| Dec 2023 | -$87.60 M(+1.0%) | -$25.19 M(+59.3%) | -$87.60 M(+1.9%) |
| Sep 2023 | - | -$15.81 M(-33.6%) | -$85.95 M(-8.8%) |
| Jun 2023 | - | -$23.80 M(+4.4%) | -$94.30 M(+5.0%) |
| Mar 2023 | - | -$22.81 M(-3.1%) | -$89.78 M(+3.5%) |
| Dec 2022 | -$86.74 M(+7.7%) | -$23.54 M(-2.5%) | -$86.74 M(+8.8%) |
| Sep 2022 | - | -$24.15 M(+25.2%) | -$79.72 M(+6.4%) |
| Jun 2022 | - | -$19.29 M(-2.4%) | -$74.90 M(-9.5%) |
| Mar 2022 | - | -$19.76 M(+19.6%) | -$82.72 M(+2.7%) |
| Dec 2021 | -$80.53 M(+115.0%) | -$16.52 M(-14.5%) | -$80.53 M(+6.5%) |
| Sep 2021 | - | -$19.33 M(-28.7%) | -$75.64 M(+13.8%) |
| Jun 2021 | - | -$27.11 M(+54.3%) | -$66.49 M(+42.9%) |
| Mar 2021 | - | -$17.57 M(+51.1%) | -$46.54 M(+24.3%) |
| Dec 2020 | -$37.45 M | -$11.63 M(+14.3%) | -$37.45 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.18 M(+42.0%) | -$31.84 M(+23.9%) |
| Jun 2020 | - | -$7.16 M(-15.6%) | -$25.70 M(+15.1%) |
| Mar 2020 | - | -$8.49 M(+41.0%) | -$22.34 M(+25.8%) |
| Dec 2019 | -$17.75 M(+84.0%) | -$6.02 M(+49.1%) | -$17.75 M(-42.2%) |
| Sep 2019 | - | -$4.04 M(+6.4%) | -$30.69 M(-67.9%) |
| Jun 2019 | - | -$3.79 M(-2.9%) | -$95.68 M(-7.9%) |
| Mar 2019 | - | -$3.90 M(-79.4%) | -$103.87 M(-20.2%) |
| Dec 2018 | -$9.65 M(+38.6%) | - | - |
| Dec 2018 | - | -$18.96 M(-72.5%) | -$130.19 M(-6.8%) |
| Sep 2018 | - | -$69.02 M(+475.7%) | -$139.62 M(+44.7%) |
| Jun 2018 | - | -$11.99 M(-60.3%) | -$96.47 M(+14.2%) |
| Mar 2018 | - | -$30.22 M(+6.5%) | -$84.48 M(+55.7%) |
| Dec 2017 | -$6.96 M | - | - |
| Dec 2017 | - | -$28.39 M(+9.7%) | -$54.26 M(+109.7%) |
| Sep 2017 | - | -$25.87 M | -$25.87 M |
FAQ
- What is Fusion Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual EBITDA year-on-year change?
- What is Fusion Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Fusion Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals TTM EBITDA year-on-year change?
What is Fusion Pharmaceuticals annual EBITDA?
The current annual EBITDA of FUSN is -$87.60 M
What is the all time high annual EBITDA for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual EBITDA is -$6.96 M
What is Fusion Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, FUSN annual EBITDA has changed by -$860.00 K (-0.99%)
What is Fusion Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of FUSN is -$31.69 M
What is the all time high quarterly EBITDA for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly EBITDA is -$3.79 M
What is Fusion Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, FUSN quarterly EBITDA has changed by -$15.89 M (-100.52%)
What is Fusion Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of FUSN is -$96.49 M
What is the all time high TTM EBITDA for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM EBITDA is -$17.75 M
What is Fusion Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, FUSN TTM EBITDA has changed by -$10.53 M (-12.25%)